Koyfin Home > Directory > Health Care > Arbutus Biopharma Cp > Gross Profit

Arbutus Biopharma Cp Gross Profit Chart (ABUS)

Arbutus Biopharma Cp annual/quarterly Gross Profit from 2010 to 2018. Gross profit is the profit after deducting the costs associated with making and selling its products, or the costs associated with providing its services. Gross profit = Revenue - Cost of Goods Sold.
  • Arbutus Biopharma Cp Gross Profit for the quarter ending December 12, 2018 was $49m a 125.80% increase of 61m year over year
  • Arbutus Biopharma Cp Gross Profit for the last 12 months ending December 12, 2018 was $6m a 961.90% increase of 57m year over year
  • Arbutus Biopharma Cp Annual Gross Profit for 2018 was $6m a 981.36% increase of 58m from 2017
  • Arbutus Biopharma Cp Annual Gross Profit for 2017 was $-52m a -3.39% increase of 2m from 2016
  • Arbutus Biopharma Cp Annual Gross Profit for 2016 was $-54m a 55.30% decrease of -30m from 2015
Other Income Statement Metrics:
  • Arbutus Biopharma Cp EBITDA for the quarter ending December 12, 2018 was $-15m a -5.44% increase of 1m year over year
  • Arbutus Biopharma Cp Net Income for the quarter ending December 12, 2018 was $-18m a 4.70% decrease of -1m year over year
  • Arbutus Biopharma Cp Total Revenue for the quarter ending December 12, 2018 was $2m a 12.06% increase of 0m year over year
View Chart On Koyfin

Quarterly ABUS Gross Profit Data

12/2018$49m
09/2018$-15m
06/2018$-15m
03/2018$-13m
12/2017$-20m
09/2017$-9m
06/2017$-14m
03/2017$-14m
12/2016$-16m
09/2016$-13m

Annual ABUS Gross Profit Data

2018$6m
2017$-52m
2016$-54m
2015$-24m
2014$-24m
2013$-6m
2012$-4m
2011$-3m
2010$-1m
2009$-3m